The current guideline has been developed by the International Diabetes Federation and ISPAD in collaboration. We tried to develop a guideline that is sensitive to resource and cost-effectiveness issues by addressing this in different "Levels of care": Recommended care, Limited care and Comprehensive care.
We hope the guidelines will be widely consulted and will be used to:
1. Improve awareness among governments, state health care providers and the general public of the serious long-term implications of poorly managed diabetes and of the essential resources needed for optimal care.
2. Assist individual care givers in managing children and adolescents with diabetes in a prompt, safe, consistent, equitable, standardised manner in accordance with the current views of experts in the field.
Latest News
The 2009 ISPAD Clinical Practice Consensus Guidelines have now been published as a compendium in a Supplement to Pediatric Diabetes. We thank the international writing teams for their efforts in writing and updating these guidelines. The editors have been: Ragnar Hanas, Kim Donaghue, Georgeanna Klingensmith and Peter GF Swift.
Click here to find the files.
Click here to find the files.
ISPAD´s prizes for 2011 were presented at the annual meeting in Miami Beach, USA. The ISPAD Prize for Achievement is the Society’s highest honour. It is awarded to any individual who has made outstanding contributions in the areas of SCIENCE, EDUCATION or ADVOCACY which have had a major impact on childhood and adolescent diabetes. The ISPAD Prize for Achievement (sponsored by Eli Lilly) may be awarded to members or non-members of ISPAD.
The 2011 Prize for Achievement was awarded to Jan Bruining from Rotterdam, The Netherlands. The Lestradet Prize for Education and Advocacy (sponsored by Lifescan) was awarded to Stu Brink from Boston, USA and the Young Investigator Award (sponsored by Medtronic) was awarded to Oscar Rubio-Cabezas from Madrid, Spain. The ISPAD Prize for Innovation in Pediatric Diabetes Care (sponsored by NovoNordisk) was given to Nick Woolfield and his diabetes team from Queensland, Australia.
The 2011 Prize for Achievement was awarded to Jan Bruining from Rotterdam, The Netherlands. The Lestradet Prize for Education and Advocacy (sponsored by Lifescan) was awarded to Stu Brink from Boston, USA and the Young Investigator Award (sponsored by Medtronic) was awarded to Oscar Rubio-Cabezas from Madrid, Spain. The ISPAD Prize for Innovation in Pediatric Diabetes Care (sponsored by NovoNordisk) was given to Nick Woolfield and his diabetes team from Queensland, Australia.
The International Diabetes Federation's Life for a Child Programme currently supports the care of 4000 children in 26 countries worldwide. The programme meets the children's immediate needs (insulin, syringes, monitoring and education), builds local capacity and lobbies governments to establish sustainable solutions. Eli Lilly is the main provider of insulin for this program.
ISPAD is a sponsor of this program and has pledged structural support and assistance in the training of pediatricians and healthcare professionals in childhood and adolescent diabetes through its membership network. Please contact the ISPAD steering committee or Graham Ogle (see ISPAD membership directory for contact details) from Life for a Child if you are interested in helping with such issues.
ISPAD is a sponsor of this program and has pledged structural support and assistance in the training of pediatricians and healthcare professionals in childhood and adolescent diabetes through its membership network. Please contact the ISPAD steering committee or Graham Ogle (see ISPAD membership directory for contact details) from Life for a Child if you are interested in helping with such issues.